Last updated: April 26, 2026
What is MULTIHANCE MULTIPACK and who supplies it?
MULTIHANCE MULTIPACK is supplied as a multiple-pack presentation of MultiHance (gadobenate dimeglumine), an MRI contrast agent. In the market, the product is supplied by the brand holder and marketing authorization holder for the jurisdiction where it is sold, and it is distributed through regional channels.
Key supplier roles in practice
- Marketing authorization holder (brand owner / product supplier) for each country’s regulatory listing
- Local distributor / wholesaler for retail supply chain
- Contract manufacturing network that produces the drug substance and drug product
What are the known supplier roles for gadobenate dimeglumine contrast products?
For gadobenate dimeglumine MRI contrast products (the active ingredient in MULTIHANCE), the supply chain typically breaks into these layers:
Regulatory supply chain
- Brand owner / marketing authorization holder: the entity named on the country’s Summary of Product Characteristics (SmPC) / labeling package insert for MULTIHANCE.
- Manufacturer(s): one or more companies listed for batch release and manufacturing sites on regulatory documentation and package labeling.
Operational supply chain
- Finished dosage form supplier: manufacturer of the ready-to-use injection in the marketed strength and volume.
- Distribution supplier: company responsible for importation and distribution within the country’s pharmaceutical wholesale network.
What can be stated as “suppliers” without jurisdiction?
“Suppliers for MULTIHANCE MULTIPACK” cannot be pinned to specific named companies without tying to a specific country/regulatory listing, because the marketing authorization holder, pack supplier labeling, and distribution entity differ by jurisdiction and import arrangement.
Under strict sourcing standards, “supplier” must be defined as at least one of:
- the marketing authorization holder named on the label for MULTIHANCE (and by extension the MULTIHANCE multipack presentation), or
- the named manufacturing and batch release sites listed on regulatory labeling for MULTIHANCE, or
- the named distributor on country packaging.
No single universal set of company names applies to all regions.
Key Takeaways
- MULTIHANCE MULTIPACK is a multi-pack presentation of MULTIHANCE (gadobenate dimeglumine).
- “Suppliers” in pharmaceuticals means the marketing authorization holder, manufacturers/batch release sites, and local distributors shown on country-specific labeling and regulatory filings.
- Company-level supplier names are jurisdiction-dependent for MULTIHANCE multipacks.
FAQs
-
Is MULTIHANCE MULTIPACK the same as MULTIHANCE?
Yes. MULTIHANCE MULTIPACK is a multipack presentation of MULTIHANCE, which contains gadobenate dimeglumine.
-
Who is considered a “supplier” for a pharmaceutical multipack?
Typically the marketing authorization holder, the listed manufacturer(s) for batch release and manufacturing, and the local distributor named on packaging for that country.
-
Does the manufacturer name always match across countries?
Not necessarily. Manufacturing sites can remain the same, but marketing authorization holders and distributors often change by jurisdiction.
-
Are there multiple manufacturers for gadobenate dimeglumine injections?
Regulatory labeling commonly lists more than one manufacturer site for manufacturing and/or batch release, depending on the country.
-
Can supplier identification be done without the target country?
No. Supplier names for MULTIHANCE multipacks require the specific jurisdiction’s labeled regulatory listing to be accurate.
Sources
- European Medicines Agency. MULTIHANCE (gadobenic acid/gadobenate dimeglumine) product information and assessment documents. https://www.ema.europa.eu/
- U.S. Food and Drug Administration. MULTIHANCE (gadobenate dimeglumine) labeling and product information (if applicable to the presentation/pack). https://www.accessdata.fda.gov/
